Recombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) versus alteplase (rt-PA) as fibrinolytic therapy for acute ST-segment elevation myocardial infarction (China TNK STEMI): protocol for a randomised, controlled, non-inferiority trial

AIM: To evaluate the efficacy and safety of recombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) in lowering major adverse cardiovascular and cerebrovascular events (MACCEs) in Chinese acute ST-segment elevation myocardial infarction (STEMI) patients. METHODS AND ANALYSIS: The study i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hai-bo, Ji, Ping, Zhao, Xing-Shan, Xu, Haiyan, Yan, Xiao-Yan, Yang, Qin, Yao, Chen, Gao, Run-Lin, Wu, Yang-feng, Qiao, Shu-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623508/
https://www.ncbi.nlm.nih.gov/pubmed/28928186
http://dx.doi.org/10.1136/bmjopen-2017-016838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623508/
https://www.ncbi.nlm.nih.gov/pubmed/28928186
http://dx.doi.org/10.1136/bmjopen-2017-016838

Ejemplares similares